New early scientific advice service to support medicine registrations

22 September 2020 - The Therapeutic Goods Administration has launched a new initiative - the Early Scientific Advice service - ...

Read more →

The antibiotic paradox: why companies can’t afford to create life-saving drugs

19 August 2020 - Paratek Pharmaceuticals successfully brought a new antibiotic to the market. So why is the company’s long-term survival ...

Read more →

Trials of a vaccine and new drug raise hope of beating COVID-19

20 July 2020 - The latest tests with Oxford University’s vaccine, and interferon beta, look promising. ...

Read more →

Many drug companies working on COVID-19 vaccines and treatments are lobbying harder than usual

20 July 2020 - Pharmaceutical companies racing to develop coronavirus treatments and vaccines have upped their lobbying presence in the ...

Read more →

Deep dive into big pharma AI productivity: one study shaking the pharmaceutical industry

15 July 2020 - The pharmaceutical business is perhaps the only industry on the planet, where to get the product from ...

Read more →

The COVID-19 vaccine development multiverse

14 July 2020 - Leaving in its wake more than 12 million infections, over 550,000 deaths, and an economic toll in ...

Read more →

WHO takes stock of global COVID-19 R&D progress

6 July 2020 - Researchers and developers meet virtually to discuss progress. ...

Read more →

The development of COVID-19 vaccines: safeguards needed

6 July 2020 - A safe and effective vaccine against coronavirus disease 2019 (COVID-19) is the best way to control and ...

Read more →

Developing a SARS-CoV-2 vaccine at warp speed

6 July 2020 - The coronavirus disease 2019 (COVID-19) pandemic has unleashed major and substantial changes in the provision of health ...

Read more →

Oxford University is leading in the vaccine race

2 July 2020 - Governments are pouring money into a more urgent version of the space race. ...

Read more →

FDA takes action to help facilitate timely development of safe, effective COVID-19 vaccines

30 June 2020 - Today, the U.S. FDA took important action to help facilitate the timely development of safe and effective ...

Read more →

Global regulators discuss data requirements for phase 3 trials of COVID-19 vaccines

24 June 2020 - Under the umbrella of the International Coalition of Medicines Regulatory Authorities, international regulators discussed COVID-19 vaccine ...

Read more →

Anti-COVID drug may be ready in Australia by the end of the year

21 June 2020 - A global breakthrough on a new antiviral drug that scientists believe could block the coronavirus has ...

Read more →

Clinical trial costs to develop a new drug may actually be rather modest — or so one study suggests

18 June 2020 - For years, the pharmaceutical industry has maintained that the costs to develop medicines accounts for rising ...

Read more →

Price limits will scare off COVID-19 vaccine makers, Fauci warns

10 June 2020 - More than one vaccine will be needed, Fauci says. ...

Read more →